InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-EB (LPS from E. coli O111:B4) | Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANopto... | 2023 | J Biol Chem. | Sharma B.R. et al. | DOI: 10.1016/j.jbc.2023.105141 |
| FLA-ST (Standard or Ultrapure) | Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANopto... | 2023 | J Biol Chem. | Sharma B.R. et al. | DOI: 10.1016/j.jbc.2023.105141 |
| Poly(dA:dT) | Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANopto... | 2023 | J Biol Chem. | Sharma B.R. et al. | DOI: 10.1016/j.jbc.2023.105141 |
| R848 (Resiquimod) | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
| CL097 | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
| Pam3CSK4 | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
| Poly(I:C) HMW | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
| ODN 2006 (ODN 7909) | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
| FLA-BS (Standard or Ultrapure) | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
| ODN 2395 VacciGrade™ | Exposure to unmethylated CpG oligonucleotides disrupts blood pressure circadi... | 2023 | Am J Physiol Heart Circ Physiol. | Bradshaw J.L. et al. | DOI: 10.1152/ajpheart.00154.2023 |
| Primocin® | Protocol to establish an oviduct epithelial cell line derived from Gallus gal... | 2023 | STAR Protoc. | Loubser C. & Nikitina N.V. | DOI: 10.1016/j.xpro.2023.102495 |
| Puromycin | Glioblastoma vascular plasticity limits effector T-cell infiltration and is b... | 2023 | Cancer Immunol Res. | Qin Z. et al. | DOI: 10.1158/2326-6066.CIR-22-0872 |
| Blasticidin | RNA-binding protein CCDC137 activates AKT signaling and promotes hepatocellul... | 2023 | J Exp Clin Cancer Res. | Tao S. et al. | DOI: 10.1186/s13046-023-02749-3 |
| Puromycin | RNA-binding protein CCDC137 activates AKT signaling and promotes hepatocellul... | 2023 | J Exp Clin Cancer Res. | Tao S. et al. | DOI: 10.1186/s13046-023-02749-3 |
| Human TLR7 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
| Human NOD2 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
| HEK-Blue™ Null2 Cells | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
| HEK-Blue™ hNOD1 | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
| Human TLR3 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |